Published in Medicine and Law Weekly, July 13th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Oculus Innovative Sciences, Inc.
Report 1: Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) announced the appointment of Jay E. Birnbaum, Ph.D., to its board of directors. Dr. Birnbaum is a pharmacologist and previous to his current role as a consultant to pharmaceutical companies, he served as vice president of global project management at Novartis/Sandoz Pharmaceuticals Corporation, where he had responsibility for strategic planning and development of the company's dermatology...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly